< Back to H.R. 2842 (103rd Congress, 1993–1994)

Text of the Women’s Midlife Health Research Act

This bill was introduced on August 3, 1993, in a previous session of Congress, but was not enacted. The text of the bill below is as of Aug 3, 1993 (Introduced).

Download PDF

Source: GPO

HR 2842 IH

103d CONGRESS

1st Session

H. R. 2842

To amend the Public Health Service Act to provide for the development or expansion of research centers on women’s midlife health, including menopause and menopausal health conditions.

IN THE HOUSE OF REPRESENTATIVES

August 3, 1993

Mrs. LLOYD (for herself, Mrs. SCHROEDER, Mrs. MALONEY, Mrs. MEEK, Ms. PELOSI, Ms. EDDIE BERNICE JOHNSON of Texas, Mrs. COLLINS of Illinois, and Ms. WOOLSEY) introduced the following bill; which was referred to the Committee on Energy and Commerce


A BILL

To amend the Public Health Service Act to provide for the development or expansion of research centers on women’s midlife health, including menopause and menopausal health conditions.

    Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ‘Women’s Midlife Health Research Act’.

SEC. 2. ESTABLISHMENT OF PROGRAM FOR RESEARCH CENTERS ON WOMEN’S MIDLIFE HEALTH CARE, INCLUDING MENOPAUSE AND MENOPAUSAL HEALTH CONDITIONS.

    Subpart 5 of part C of title IV of the Public Health Service Act (42 U.S.C. 285e et seq.) is amended by adding at the end the following section:

‘RESEARCH CENTERS ON MENOPAUSE AND MENOPAUSAL HEALTH CONDITIONS

    ‘SEC. 445G. (a) The Director of the Institute, after consultation with the advisory council for the Institute, shall provide for the development or expansion of not less than 5 centers for research on--

      ‘(1) the process by which the functioning of the ovaries diminishes or ceases completely (in this section referred to as ‘menopause’); and

      ‘(2) conditions arising from the diminished or complete cessation of the functioning of the ovaries, whether occurring naturally or otherwise (in this section referred to as ‘menopausal health conditions’).

    ‘(b) Each center assisted under this section shall--

      ‘(1)(A) use the facilities of a single institution or a consortium of cooperating institutions; and

      ‘(B) meet such qualifications as may be prescribed by the Secretary;

      ‘(2) conduct basic and clinical research into the natural history of menopause in order to improve the state of medical knowledge or methods regarding the cause, diagnosis, early detection, prevention, control, and treatment of menopausal health conditions;

      ‘(3) develop multidisciplinary models of health care regarding menopause and menopausal health conditions;

      ‘(4) conduct educational and training programs on menopause and menopausal health conditions for physicians, scientists, and other health and allied health professionals;

      ‘(5) conduct information and continuing education programs for physicians and other health and allied health professionals who provide care for patients with such conditions; and

      ‘(6) conduct programs for the dissemination to the general public of information on menopause and menopausal health conditions.

    ‘(c) In carrying out subsection (b)(2), the Director of the Institute shall ensure that centers assisted under this section--

      ‘(1) conduct research on hormonal treatments for menopausal health conditions, research on nonhormonal treatments of symptoms arising from such conditions, and research on the relationship between such conditions and cardiovascular disease, osteoporosis, bone fractures, bladder conditions, breast and uterine cancers, and other conditions that research indicates may be relevant; and

      ‘(2) conduct research to determine whether and to what extent differences may exist, with respect to menopause and menopausal health conditions, among various socioeconomic groups, ethnic groups, and racial groups.

    ‘(d) In carrying out subsection (a), the Director of the Institute, in consultation with the Director of NIH and the Administrator for Health Care Policy and Research, shall establish a program to develop protocols for the prevention and treatment of menopausal health conditions and other conditions regarding women’s midlife health.

    ‘(e) A center may use funds provided under subsection (a) to provide stipends for health professionals enrolled in educational or training programs described in subsection (b)(4).

    ‘(f) The Director shall ensure that the activities of centers assisted under this section are coordinated among the centers.

    ‘(g) The Director of the Institute shall, to the extent practicable, provide for an equitable geographical distribution of centers assisted under this section.

    ‘(h) Support of a center under this section may be for a period of not to exceed five years. Such period may be extended by the Director of the Institute for one or more additional periods of not more than five years if the operations of such center have been reviewed by an appropriate technical and scientific peer review group established by the Director and if such group has recommended to the Director that such period should be extended.’.